The main focus behind the study is to provide reliable hospital based estimates of genetic influence, and to characterize the nature and prevalence of BRCA1 and BRCA2 germline mutations in early-onset and familial breast cancer cases. This evidence concerns the gene BRCA1 and breast cancer.